<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2023-699</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-802</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEW</subject></subj-group></article-categories><title-group><article-title>Нейровоспаление и его роль в патогенезе синдрома дефицита внимания с гиперактивностью (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Neuroinflammation and its role in the pathogenesis of attention deficit hyperactivity disorder (literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3045-333X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гасанов</surname><given-names>Р. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Gasanov</surname><given-names>R. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гасанов Рауф Фаикович - к.м.н., ведущий научный сотрудник отделения детской психиатрии</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Rauf F. Gasanov</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">raufgasanov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0176-3846</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макаров</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarov</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макаров Игорь Владимирович - д.м.н., профессор, руководитель отделения детской психиатрии; профессор кафедры психиатрии и наркологии; главный внештатный детский специалист психиатр Минздрава России в Северо-Западном федеральном округе, председатель секции детской психиатрии Российского общества психиатров</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Igor V. Makarov</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">ppsy@list.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8189-1479</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Емелина</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Emelina</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Емелина Дарья Андреевна - к.м.н., научный сотрудник отделения детской психиатрии</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Daria A. Emelina</p><p>Saint-Petersburg</p></bio><email xlink:type="simple">dashaberkos@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6216-7728</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Автенюк</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Avtenuk</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Автенюк Антон Сергеевич - к.м.н., научный сотрудник отделения детской психиатрии</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Anton S. Avtenuk</p><p>Saint-Petersburg</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National medical research center for psychiatry and neurology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева; Северо-Западный государственный медицинский университет им. И.И. Мечникова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National medical research center for psychiatry and neurology; North-Western State Medical University named after I.I. Mechnikov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>08</day><month>04</month><year>2023</year></pub-date><volume>57</volume><issue>1</issue><fpage>8</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гасанов Р.Ф., Макаров И.В., Емелина Д.А., Автенюк А.С., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Гасанов Р.Ф., Макаров И.В., Емелина Д.А., Автенюк А.С.</copyright-holder><copyright-holder xml:lang="en">Gasanov R.F., Makarov I.V., Emelina D.A., Avtenuk A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/802">https://www.bekhterevreview.com/jour/article/view/802</self-uri><abstract><p>В статье рассматривается роль воспалительных реакций в формировании синдрома дефицита внимания с гиперактивностью (СДВГ). На широком и современном материале рассматриваются механизмы развития окислительного стресса с образованием свободных радикалов, которые, в свою очередь, инициируют каскад воспалительных реакций. Подробно разбираются факторы воспаления, выделяются биомаркеры нейровоспаления и раскрывается их роль в изменении нейротрасмиттерного баланса. Биомаркеры нейровоспаления, выделенные у пациентов с СДВГ, дают противоречивые результаты в некоторых частных вопросах, которые, безусловно требуют уточнения. Но в целом обнаруживают, что усиление воспаления на ранних стадиях развития мозга, по-видимому, связано с фенотипом СДВГ. СДВГ, как принято считать, — наследственное заболевание; следовательно, можно ожидать, что у пациентов присутствуют полиморфизмы генов, связанных с воспалением, что проиллюстрировано на широком материале.Кроме того, рассматриваются проблемы индукции нейровоспаления традиционными для лечения СДВГ препаратами: метилфенидатом и атомоксетином. Отмечается перспективность разработки алгоритмов диагностики и терапии синдрома дефицита внимания с гиперактивностью.</p></abstract><trans-abstract xml:lang="en"><p>The article discusses the role of inflammatory reactions in the formation of attention deficit hyperactivity disorder (ADHD). Based on a wide and modern material, the mechanisms of development of oxidative stress with the formation of free radicals are considered, which, in turn, initiate a cascade of inflammatory reactions. Inflammation factors are analyzed in detail, biomarkers of neuroinflammation are distinguished and their role in changing the neurotransmitter balance is revealed. Biomarkers of neuroinflammation isolated from patients with ADHD give conflicting results in some particular issues, which certainly require clarification. But in general, it is found that increased inflammation in the early stages of brain development seems to be associated with the ADHD phenotype. ADHD is commonly believed to be a hereditary disease; therefore, it can be expected that patients have polymorphisms of genes associated with inflammation, which is illustrated in a wide range of material. In addition, the problems of inducing neuroinflammation with traditional drugs for the treatment of ADHD: methylphenidate and atomoxetine are considered. The prospects of developing algorithms for the diagnosis and treatment of attention deficit hyperactivity disorder are noted.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нейровоспаление</kwd><kwd>синдром дефицита внимания с гиперактивностью</kwd><kwd>окислительный стресс</kwd><kwd>нейротрансмиттеры</kwd><kwd>интерлейкины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neuroinflammation</kwd><kwd>attention deficit hyperactivity disorder</kwd><kwd>oxidative stress</kwd><kwd>neurotransmitters</kwd><kwd>interleukins</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2:734–744. doi: 10.1038/35094583.</mixed-citation><mixed-citation xml:lang="en">Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2:734–744. doi: 10.1038/35094583.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL. Attention-deficit/ hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front. Psychiatry. 2017;8:228. doi: 10.3389/ fpsyt.2017.00228.</mixed-citation><mixed-citation xml:lang="en">Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL. Attention-deficit/ hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front. Psychiatry. 2017;8:228. doi: 10.3389/ fpsyt.2017.00228.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Andreazza AC, Frey BN, Valvassori SS, Zanotto C, Gomes KM, et al. DNA damage in rats after treatment with methylphenidate. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007;31:1282–1288. doi: 10.1016/j.pnpbp.2007.05.012.</mixed-citation><mixed-citation xml:lang="en">Andreazza AC, Frey BN, Valvassori SS, Zanotto C, Gomes KM, et al. DNA damage in rats after treatment with methylphenidate. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2007;31:1282–1288. doi: 10.1016/j.pnpbp.2007.05.012.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Aspide R, Gironi Carnevale UA, Sergeant JA, Sadile AG. Non-selective attention and nitric oxide in putative animal models of Attention-Deficit Hyperactivity Disorder. Behav. Brain Res. 1998;95:123–133. doi: 10.1016/s0166-4328(97)00217-9.</mixed-citation><mixed-citation xml:lang="en">Aspide R, Gironi Carnevale UA, Sergeant JA, Sadile AG. Non-selective attention and nitric oxide in putative animal models of Attention-Deficit Hyperactivity Disorder. Behav. Brain Res. 1998;95:123–133. doi: 10.1016/s0166-4328(97)00217-9.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Avcil S, Uysal P, Yenisey Ç, Abas BI. Elevated Melatonin Levels in Children With Attention Deficit Hyperactivity Disorder: Relationship to Oxidative and Nitrosative Stress. J Atten Disord. 2021;25(5):693-703. doi: 10.1177/1087054719829816.</mixed-citation><mixed-citation xml:lang="en">Avcil S, Uysal P, Yenisey Ç, Abas BI. Elevated Melatonin Levels in Children With Attention Deficit Hyperactivity Disorder: Relationship to Oxidative and Nitrosative Stress. J Atten Disord. 2021;25(5):693-703. doi: 10.1177/1087054719829816.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Barry DS, Pakan JM, McDermott KW. Radial glial cells: key organisers in CNS development. Int J Biochem Cell Biol. 2014;46:76–79. doi: 10.1016/j.biocel.2013.11.013.</mixed-citation><mixed-citation xml:lang="en">Barry DS, Pakan JM, McDermott KW. Radial glial cells: key organisers in CNS development. Int J Biochem Cell Biol. 2014;46:76–79. doi: 10.1016/j.biocel.2013.11.013.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Baune BT, Wiede F, Braun A, Golledge J, Arolt V, Koerner H. Cognitive dysfunction in mice deficient for TNF- and its receptors. Am J Med Genet B Neuropsychiatr Genet. 2008 O;147B(7):1056-1064. doi: 10.1002/ajmg.b.30712.</mixed-citation><mixed-citation xml:lang="en">Baune BT, Wiede F, Braun A, Golledge J, Arolt V, Koerner H. Cognitive dysfunction in mice deficient for TNF- and its receptors. Am J Med Genet B Neuropsychiatr Genet. 2008 O;147B(7):1056-1064. doi: 10.1002/ajmg.b.30712.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Becker K, El-Faddagh M, Schmidt MH, Esser G, Laucht M. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. J Pediatr. 2008;152(2):263-269. doi: 10.1016/j.jpeds.2007.07.004.</mixed-citation><mixed-citation xml:lang="en">Becker K, El-Faddagh M, Schmidt MH, Esser G, Laucht M. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. J Pediatr. 2008;152(2):263-269. doi: 10.1016/j.jpeds.2007.07.004.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Beste C, Baune BT, Falkenstein M, Konrad C. Variations in the TNF-α gene (TNF-α -308G→A) affect attention and action selection mechanisms in a dissociated fashion. J Neurophysiol. 2010;104(5):2523-2531. doi: 10.1152/jn.00561.2010.</mixed-citation><mixed-citation xml:lang="en">Beste C, Baune BT, Falkenstein M, Konrad C. Variations in the TNF-α gene (TNF-α -308G→A) affect attention and action selection mechanisms in a dissociated fashion. J Neurophysiol. 2010;104(5):2523-2531. doi: 10.1152/jn.00561.2010.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Borovcanin, M.M., Jovanovic, I., Radosavljevic,</mixed-citation><mixed-citation xml:lang="en">Borovcanin, M.M., Jovanovic, I., Radosavljevic,</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">G., Pantic, J., Janicijevic, S.M., et al. Interleukin-6 in schizophrenia-is there a therapeutic relevance? Front. Psychiatry. 2017;8:221. doi: 10.3389/ fpsyt.2017.00221.</mixed-citation><mixed-citation xml:lang="en">G., Pantic, J., Janicijevic, S.M., et al. Interleukin-6 in schizophrenia-is there a therapeutic relevance? Front. Psychiatry. 2017;8:221. doi: 10.3389/ fpsyt.2017.00221.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bourgognon JM, Cavanagh J. The role of cytokines in modulating learning and memory and brain plasticity. Brain Neurosci Adv. 2020;4:2398212820979802. doi: 10.1177/2398212820979802.</mixed-citation><mixed-citation xml:lang="en">Bourgognon JM, Cavanagh J. The role of cytokines in modulating learning and memory and brain plasticity. Brain Neurosci Adv. 2020;4:2398212820979802. doi: 10.1177/2398212820979802.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bulut M, Selek S, Gergerlioglu HS, Savas HA, Yilmaz HR, et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci. 2007;32(6):435-438.</mixed-citation><mixed-citation xml:lang="en">Bulut M, Selek S, Gergerlioglu HS, Savas HA, Yilmaz HR, et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci. 2007;32(6):435-438.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bulut M, Selek S, Bez Y, Cemal Kaya M, Gunes M, et al. Lipid peroxidation markers in adult attention deficit hyperactivity disorder: new findings for oxidative stress. Psychiatry Res. 2013;209(3):638-642. doi: 10.1016/j.psychres.2013.02.025.</mixed-citation><mixed-citation xml:lang="en">Bulut M, Selek S, Bez Y, Cemal Kaya M, Gunes M, et al. Lipid peroxidation markers in adult attention deficit hyperactivity disorder: new findings for oxidative stress. Psychiatry Res. 2013;209(3):638-642. doi: 10.1016/j.psychres.2013.02.025.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology. 2013;38(1):12-23. doi: 10.1016/j.psyneuen.2012.09.017.</mixed-citation><mixed-citation xml:lang="en">Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology. 2013;38(1):12-23. doi: 10.1016/j.psyneuen.2012.09.017.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology. 2002;27(5):699-711. doi: 10.1016/S0893-133X(02)00346-9.</mixed-citation><mixed-citation xml:lang="en">Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology. 2002;27(5):699-711. doi: 10.1016/S0893-133X(02)00346-9.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ceylan M, Sener S, Bayraktar AC, Kavutcu M. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(8):1491-1494. doi: 10.1016/j.pnpbp.2010.08.010.</mixed-citation><mixed-citation xml:lang="en">Ceylan M, Sener S, Bayraktar AC, Kavutcu M. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(8):1491-1494. doi: 10.1016/j.pnpbp.2010.08.010.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ceylan MF, Sener S, Bayraktar AC, Kavutcu M. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci. 2012;66(3):220-6. doi: 10.1111/j.1440-1819.2012.02330.x.</mixed-citation><mixed-citation xml:lang="en">Ceylan MF, Sener S, Bayraktar AC, Kavutcu M. Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci. 2012;66(3):220-6. doi: 10.1111/j.1440-1819.2012.02330.x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chang JP, Mondelli V, Satyanarayanan SK, Chiang YJ, Chen HT, Su KP, Pariante CM. Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Brain Behav Immun. 2020;88:105-113. doi: 10.1016/j.bbi.2020.05.017.</mixed-citation><mixed-citation xml:lang="en">Chang JP, Mondelli V, Satyanarayanan SK, Chiang YJ, Chen HT, Su KP, Pariante CM. Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Brain Behav Immun. 2020;88:105-113. doi: 10.1016/j.bbi.2020.05.017.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chovanová Z, Muchová J, Sivonová M, Dvoráková M, Zitnanová I, et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res. 2006;40(9):1003-1010. doi: 10.1080/10715760600824902.</mixed-citation><mixed-citation xml:lang="en">Chovanová Z, Muchová J, Sivonová M, Dvoráková M, Zitnanová I, et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res. 2006;40(9):1003-1010. doi: 10.1080/10715760600824902.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salomäki S, Sucksdorff M, et al. Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2020;29(2):239-247. doi: 10.1007/s00787-019-01372-y.</mixed-citation><mixed-citation xml:lang="en">Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salomäki S, Sucksdorff M, et al. Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2020;29(2):239-247. doi: 10.1007/s00787-019-01372-y.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018;15:490-503. doi: 10.1016/j.redox.2018.01.008</mixed-citation><mixed-citation xml:lang="en">Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018;15:490-503. doi: 10.1016/j.redox.2018.01.008</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Corona JC, Duchen MR. Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets? J BioenergBiomembr. 2015;47(1-2):89-99. doi: 10.1007/s10863-014-9576-6.</mixed-citation><mixed-citation xml:lang="en">Corona JC, Duchen MR. Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets? J BioenergBiomembr. 2015;47(1-2):89-99. doi: 10.1007/s10863-014-9576-6.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Corona JC, Carreon-Trujillo S, Gonzalez-Perez R, Gomez-Bautista D, Vazquez-Gonzalez D, et al. Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells. Sci. Rep. 2019; 9:13011. doi: 10.1038/s41598-019-49609-9.</mixed-citation><mixed-citation xml:lang="en">Corona JC, Carreon-Trujillo S, Gonzalez-Perez R, Gomez-Bautista D, Vazquez-Gonzalez D, et al. Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells. Sci. Rep. 2019; 9:13011. doi: 10.1038/s41598-019-49609-9.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Cortese S. The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): what every clinician should know. Eur J Paediatr Neurol. 2012;16(5):422-433. doi: 10.1016/j.ejpn.2012.01.009.</mixed-citation><mixed-citation xml:lang="en">Cortese S. The neurobiology and genetics of Attention-Deficit/Hyperactivity Disorder (ADHD): what every clinician should know. Eur J Paediatr Neurol. 2012;16(5):422-433. doi: 10.1016/j.ejpn.2012.01.009.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cunningham CL, Martínez-Cerdeño V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33(10):4216-4233. doi: 10.1523/JNEUROSCI.3441-12.2013.</mixed-citation><mixed-citation xml:lang="en">Cunningham CL, Martínez-Cerdeño V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33(10):4216-4233. doi: 10.1523/JNEUROSCI.3441-12.2013.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Darwish AH, Elgohary TM, Nosair NA. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD). J Child Neurol. 2019;34(2):61-67. doi: 10.1177/0883073818809831.</mixed-citation><mixed-citation xml:lang="en">Darwish AH, Elgohary TM, Nosair NA. Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD). J Child Neurol. 2019;34(2):61-67. doi: 10.1177/0883073818809831.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">de Araújo Boleti AP, de Oliveira Flores TM, Moreno SE, Anjos LD, Mortari MR, Migliolo L. Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies. Neurochem Int. 2020;136:104714. doi: 10.1016/j.neuint.2020.104714.</mixed-citation><mixed-citation xml:lang="en">de Araújo Boleti AP, de Oliveira Flores TM, Moreno SE, Anjos LD, Mortari MR, Migliolo L. Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies. Neurochem Int. 2020;136:104714. doi: 10.1016/j.neuint.2020.104714.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">de Jong S, Newhouse SJ, Patel H, Lee S, Dempster D, et al. Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis. Br J Psychiatry. 2016;209(3):202-208. doi: 10.1192/bjp.bp.115.175471.</mixed-citation><mixed-citation xml:lang="en">de Jong S, Newhouse SJ, Patel H, Lee S, Dempster D, et al. Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis. Br J Psychiatry. 2016;209(3):202-208. doi: 10.1192/bjp.bp.115.175471.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Demontis, D., Walters, R.K., Martin, J., Mattheisen, M., Als, T.D., Agerbo, E., et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 2019;51:63–75. doi: 10.1038/s41588-018-0269-7.</mixed-citation><mixed-citation xml:lang="en">Demontis, D., Walters, R.K., Martin, J., Mattheisen, M., Als, T.D., Agerbo, E., et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 2019;51:63–75. doi: 10.1038/s41588-018-0269-7.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Donfrancesco R, Nativio P, Di Benedetto A, Villa MP, Andriola E, Melegari MG, et al. Anti-Yo Antibodies in Children With ADHD: First Results About Serum Cytokines. J Atten Disord. 2020;24(11):1497-1502. doi: 10.1177/1087054716643387.</mixed-citation><mixed-citation xml:lang="en">Donfrancesco R, Nativio P, Di Benedetto A, Villa MP, Andriola E, Melegari MG, et al. Anti-Yo Antibodies in Children With ADHD: First Results About Serum Cytokines. J Atten Disord. 2020;24(11):1497-1502. doi: 10.1177/1087054716643387.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Dunn GA, Nigg JT, Sullivan EL. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. PharmacolBiochemBehav. 2019;182:22-34. doi: 10.1016/j.pbb.2019.05.005.</mixed-citation><mixed-citation xml:lang="en">Dunn GA, Nigg JT, Sullivan EL. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. PharmacolBiochemBehav. 2019;182:22-34. doi: 10.1016/j.pbb.2019.05.005.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Dursun S, Demirci E, Kilic E, Ozmen S. A Different View on the Etiopathogenesis of Attentiondeficit Hyperactivity Disorder from an Inflammation Perspective. Clin PsychopharmacolNeurosci. 2021;19(1):145-154. doi: 10.9758/cpn.2021.19.1.145.</mixed-citation><mixed-citation xml:lang="en">Dursun S, Demirci E, Kilic E, Ozmen S. A Different View on the Etiopathogenesis of Attentiondeficit Hyperactivity Disorder from an Inflammation Perspective. Clin PsychopharmacolNeurosci. 2021;19(1):145-154. doi: 10.9758/cpn.2021.19.1.145.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Dutt M, Dharavath RN, Kaur T, Chopra K, Sharma S. Differential effects of alprazolam against methylphenidate-induced neurobehavioral alterations. PhysiolBehav. 2020;222:112935. doi: 10.1016/j.physbeh.2020.112935.</mixed-citation><mixed-citation xml:lang="en">Dutt M, Dharavath RN, Kaur T, Chopra K, Sharma S. Differential effects of alprazolam against methylphenidate-induced neurobehavioral alterations. PhysiolBehav. 2020;222:112935. doi: 10.1016/j.physbeh.2020.112935.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254-1266. doi: 10.7150/ijbs.4679.</mixed-citation><mixed-citation xml:lang="en">Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254-1266. doi: 10.7150/ijbs.4679.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Eyo UB, Dailey ME. Microglia: key elements in neural development, plasticity, and pathology. J Neuroimmune Pharmacol. 2013;8(3):494-509. doi: 10.1007/s11481-013-9434-z.</mixed-citation><mixed-citation xml:lang="en">Eyo UB, Dailey ME. Microglia: key elements in neural development, plasticity, and pathology. J Neuroimmune Pharmacol. 2013;8(3):494-509. doi: 10.1007/s11481-013-9434-z.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Fagundes AO, Rezin GT, Zanette F, Grandi E, Assis LC, Dal-Pizzol F, et al. Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats. Int J Dev Neurosci. 2007;25(1):47-51. doi: 10.1016/j.ijdevneu.2006.11.001.</mixed-citation><mixed-citation xml:lang="en">Fagundes AO, Rezin GT, Zanette F, Grandi E, Assis LC, Dal-Pizzol F, et al. Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats. Int J Dev Neurosci. 2007;25(1):47-51. doi: 10.1016/j.ijdevneu.2006.11.001.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, Knight AR, et al. Clinical Relevance of Biomarkers of Oxidative Stress. Antioxid Redox Signal. 2015;23(14):1144-1170. doi: 10.1089/ars.2015.6317.</mixed-citation><mixed-citation xml:lang="en">Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, Knight AR, et al. Clinical Relevance of Biomarkers of Oxidative Stress. Antioxid Redox Signal. 2015;23(14):1144-1170. doi: 10.1089/ars.2015.6317.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Goldsmith DR, Rapaport MH, Miller BJ. A metaanalysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696-1709. doi: 10.1038/mp.2016.3.</mixed-citation><mixed-citation xml:lang="en">Goldsmith DR, Rapaport MH, Miller BJ. A metaanalysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696-1709. doi: 10.1038/mp.2016.3.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Goldstein DS, Kopin IJ, Sharabi Y. Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. PharmacolTher. 2014;144(3):268-282. doi: 10.1016/j.pharmthera.2014.06.006.</mixed-citation><mixed-citation xml:lang="en">Goldstein DS, Kopin IJ, Sharabi Y. Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. PharmacolTher. 2014;144(3):268-282. doi: 10.1016/j.pharmthera.2014.06.006.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Gomes KM, Inácio CG, Valvassori SS, Réus GZ, Boeck CR, Dal-Pizzol F, Quevedo J. Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats. Neurosci Lett. 2009;465(1):95-98. doi: 10.1016/j.neulet.2009.08.060.</mixed-citation><mixed-citation xml:lang="en">Gomes KM, Inácio CG, Valvassori SS, Réus GZ, Boeck CR, Dal-Pizzol F, Quevedo J. Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats. Neurosci Lett. 2009;465(1):95-98. doi: 10.1016/j.neulet.2009.08.060.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Gomes KM, Petronilho FC, Mantovani M, Garbelotto T, Boeck CR, Dal-Pizzol F, Quevedo J. Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochem Res. 2008;33(6):1024-1027. doi: 10.1007/s11064-007-9544-1.</mixed-citation><mixed-citation xml:lang="en">Gomes KM, Petronilho FC, Mantovani M, Garbelotto T, Boeck CR, Dal-Pizzol F, Quevedo J. Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochem Res. 2008;33(6):1024-1027. doi: 10.1007/s11064-007-9544-1.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Gustafsson HC, Sullivan EL, Battison EAJ, Holton KF, Graham AM, et al. Evaluation of maternal inflammation as a marker of future offspring ADHD symptoms: A prospective investigation. Brain Behav Immun. 2020;89:350-356. doi: 10.1016/j.bbi.2020.07.019.</mixed-citation><mixed-citation xml:lang="en">Gustafsson HC, Sullivan EL, Battison EAJ, Holton KF, Graham AM, et al. Evaluation of maternal inflammation as a marker of future offspring ADHD symptoms: A prospective investigation. Brain Behav Immun. 2020;89:350-356. doi: 10.1016/j.bbi.2020.07.019.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Hassan W, Noreen H, Castro-Gomes V, Mohammadzai I, da Rocha JB, Landeira-Fernandez J. Association of Oxidative Stress with Psychiatric Disorders. Curr Pharm Des. 2016;22(20):2960-2974. doi: 10.2174/1381612822666160307145931.</mixed-citation><mixed-citation xml:lang="en">Hassan W, Noreen H, Castro-Gomes V, Mohammadzai I, da Rocha JB, Landeira-Fernandez J. Association of Oxidative Stress with Psychiatric Disorders. Curr Pharm Des. 2016;22(20):2960-2974. doi: 10.2174/1381612822666160307145931.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Hegvik TA, Instanes JT, Haavik J, Klungsøyr K, Engeland A. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based crosssectional study. Eur Child Adolesc Psychiatry. 2018;27(5):663-675. doi: 10.1007/s00787-017-1056-1.</mixed-citation><mixed-citation xml:lang="en">Hegvik TA, Instanes JT, Haavik J, Klungsøyr K, Engeland A. Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based crosssectional study. Eur Child Adolesc Psychiatry. 2018;27(5):663-675. doi: 10.1007/s00787-017-1056-1.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171- 186. doi: 10.1097/PSY.0b013e3181907c1b.</mixed-citation><mixed-citation xml:lang="en">Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171- 186. doi: 10.1097/PSY.0b013e3181907c1b.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448-457. doi: 10.1038/ni.3153.</mixed-citation><mixed-citation xml:lang="en">Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448-457. doi: 10.1038/ni.3153.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Instanes JT, Halmøy A, Engeland A, Haavik J, Furu K, Klungsøyr K. Attention-Deficit/Hyperactivity Disorder in Offspring of Mothers With Inflammatory and Immune System Diseases. Biol Psychiatry. 2017;81(5):452-459. doi: 10.1016/j.biopsych.2015.11.024.</mixed-citation><mixed-citation xml:lang="en">Instanes JT, Halmøy A, Engeland A, Haavik J, Furu K, Klungsøyr K. Attention-Deficit/Hyperactivity Disorder in Offspring of Mothers With Inflammatory and Immune System Diseases. Biol Psychiatry. 2017;81(5):452-459. doi: 10.1016/j.biopsych.2015.11.024.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Joseph N, Zhang-James Y, Perl A, Faraone SV. Oxidative Stress and ADHD: A Meta-Analysis. J Atten Disord. 2015;19(11):915-924. doi: 10.1177/1087054713510354.</mixed-citation><mixed-citation xml:lang="en">Joseph N, Zhang-James Y, Perl A, Faraone SV. Oxidative Stress and ADHD: A Meta-Analysis. J Atten Disord. 2015;19(11):915-924. doi: 10.1177/1087054713510354.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Karababa İF, Savas SN, Selek S, Cicek E, Cicek EI, et al. Homocysteine Levels and Oxidative Stress Parameters in Patients With Adult ADHD. J Atten Disord. 2017;21(6):487-493. doi: 10.1177/1087054714538657.</mixed-citation><mixed-citation xml:lang="en">Karababa İF, Savas SN, Selek S, Cicek E, Cicek EI, et al. Homocysteine Levels and Oxidative Stress Parameters in Patients With Adult ADHD. J Atten Disord. 2017;21(6):487-493. doi: 10.1177/1087054714538657.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Kawatani M, Tsukahara H, Mayumi M. Evaluation of oxidative stress status in children with pervasive developmental disorder and attention deficit hyperactivity disorder using urinary-specific biomarkers. Redox Rep. 2011;16(1):45-46. doi: 10.1179/174329211X12968219310873.</mixed-citation><mixed-citation xml:lang="en">Kawatani M, Tsukahara H, Mayumi M. Evaluation of oxidative stress status in children with pervasive developmental disorder and attention deficit hyperactivity disorder using urinary-specific biomarkers. Redox Rep. 2011;16(1):45-46. doi: 10.1179/174329211X12968219310873.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Kitaoka T, Morimoto M, Hashimoto T, Tsuda Y, Nakatsu T, Kyotani S. Evaluation of the efficacy of drug treatment based on measurement of the oxidative stress, using reactive oxygen metabolites and biological antioxidant potential, in children with autism spectrum disorder and attention deficit hyperactivity disorder. J Pharm Health Care Sci. 2020;6:8. doi: 10.1186/s40780-020-00164-w.</mixed-citation><mixed-citation xml:lang="en">Kitaoka T, Morimoto M, Hashimoto T, Tsuda Y, Nakatsu T, Kyotani S. Evaluation of the efficacy of drug treatment based on measurement of the oxidative stress, using reactive oxygen metabolites and biological antioxidant potential, in children with autism spectrum disorder and attention deficit hyperactivity disorder. J Pharm Health Care Sci. 2020;6:8. doi: 10.1186/s40780-020-00164-w.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Kozłowska A, Wojtacha P, Równiak M, Kolenkiewicz M, Huang ACW. ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats. Psychopharmacology (Berl). 2019;236(10):2937-2958. doi: 10.1007/s00213-019-5180-0.</mixed-citation><mixed-citation xml:lang="en">Kozłowska A, Wojtacha P, Równiak M, Kolenkiewicz M, Huang ACW. ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats. Psychopharmacology (Berl). 2019;236(10):2937-2958. doi: 10.1007/s00213-019-5180-0.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157(5):683-694. doi: 10.1176/appi.ajp.157.5.683.</mixed-citation><mixed-citation xml:lang="en">Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157(5):683-694. doi: 10.1176/appi.ajp.157.5.683.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Lacosta S, Merali Z, Anisman H. Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology (Berl). 1998;137(4):351-361. doi: 10.1007/s002130050630.</mixed-citation><mixed-citation xml:lang="en">Lacosta S, Merali Z, Anisman H. Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology (Berl). 1998;137(4):351-361. doi: 10.1007/s002130050630.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Landaas ET, Johansson S, Jacobsen KK, Ribasés M, Bosch R, et al. An international multicenter association study of the serotonin transporter gene in persistent ADHD. Genes Brain Behav. 2010;9(5):449-458. doi: 10.1111/j.1601-183X.2010.00567.x.</mixed-citation><mixed-citation xml:lang="en">Landaas ET, Johansson S, Jacobsen KK, Ribasés M, Bosch R, et al. An international multicenter association study of the serotonin transporter gene in persistent ADHD. Genes Brain Behav. 2010;9(5):449-458. doi: 10.1111/j.1601-183X.2010.00567.x.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Leffa DT, Torres ILS, Rohde LA. A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder. Neuroimmunomodulation. 2018;25(5-6):328-333. doi: 10.1159/000489635.</mixed-citation><mixed-citation xml:lang="en">Leffa DT, Torres ILS, Rohde LA. A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder. Neuroimmunomodulation. 2018;25(5-6):328-333. doi: 10.1159/000489635.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Leffa DT, Bellaver B, de Oliveira C, de Macedo IC, de Freitas JS, et al. Increased Oxidative Parameters and Decreased Cytokine Levels in an Animal Model of Attention-Deficit/Hyperactivity Disorder. Neurochem Res. 2017;42(11):3084-3092. doi: 10.1007/s11064-017-2341-6.</mixed-citation><mixed-citation xml:lang="en">Leffa DT, Bellaver B, de Oliveira C, de Macedo IC, de Freitas JS, et al. Increased Oxidative Parameters and Decreased Cytokine Levels in an Animal Model of Attention-Deficit/Hyperactivity Disorder. Neurochem Res. 2017;42(11):3084-3092. doi: 10.1007/s11064-017-2341-6.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Li YJ, Xie XN, Lei X, Li YM, Lei X. Global prevalence of obesity, overweight and underweight in children, adolescents and adults with autism spectrum disorder, attention-deficit hyperactivity disorder: A systematic review and meta-analysis. Obes Rev. 2020;21(12):e13123. doi: 10.1111/obr.13123.</mixed-citation><mixed-citation xml:lang="en">Li YJ, Xie XN, Lei X, Li YM, Lei X. Global prevalence of obesity, overweight and underweight in children, adolescents and adults with autism spectrum disorder, attention-deficit hyperactivity disorder: A systematic review and meta-analysis. Obes Rev. 2020;21(12):e13123. doi: 10.1111/obr.13123.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Martins MR, Reinke A, Petronilho FC, Gomes KM, Dal-Pizzol F, Quevedo J. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res. 2006;1078(1):189-197. doi: 10.1016/j.brainres.2006.01.004.</mixed-citation><mixed-citation xml:lang="en">Martins MR, Reinke A, Petronilho FC, Gomes KM, Dal-Pizzol F, Quevedo J. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res. 2006;1078(1):189-197. doi: 10.1016/j.brainres.2006.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Mattei D, Ivanov A, Ferrai C, Jordan P, Guneykaya D, Buonfiglioli A, et al. Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment. Transl Psychiatry. 2017;7(5):e1120. doi: 10.1038/tp.2017.80.</mixed-citation><mixed-citation xml:lang="en">Mattei D, Ivanov A, Ferrai C, Jordan P, Guneykaya D, Buonfiglioli A, et al. Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment. Transl Psychiatry. 2017;7(5):e1120. doi: 10.1038/tp.2017.80.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Métin C, Vallee RB, Rakic P, Bhide PG. Modes and mishaps of neuronal migration in the mammalian brain. J Neurosci. 2008;28(46):11746-52. doi: 10.1523/JNEUROSCI.3860-08.2008.</mixed-citation><mixed-citation xml:lang="en">Métin C, Vallee RB, Rakic P, Bhide PG. Modes and mishaps of neuronal migration in the mammalian brain. J Neurosci. 2008;28(46):11746-52. doi: 10.1523/JNEUROSCI.3860-08.2008.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70(7):663-671. doi: 10.1016/j.biopsych.2011.04.013.</mixed-citation><mixed-citation xml:lang="en">Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70(7):663-671. doi: 10.1016/j.biopsych.2011.04.013.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Misener VL, Schachar R, Ickowicz A, Malone M, Roberts W, Tannock R, et al. Replication test for association of the IL-1 receptor antagonist gene, IL1RN, with attention-deficit/hyperactivity disorder. Neuropsychobiology. 2004;50(3):231-234. doi: 10.1159/000079976.</mixed-citation><mixed-citation xml:lang="en">Misener VL, Schachar R, Ickowicz A, Malone M, Roberts W, Tannock R, et al. Replication test for association of the IL-1 receptor antagonist gene, IL1RN, with attention-deficit/hyperactivity disorder. Neuropsychobiology. 2004;50(3):231-234. doi: 10.1159/000079976.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Misiak B, Wójta-Kempa M, Samochowiec J, Schiweck C, Aichholzer M, et al. Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2022;118:110581. doi: 10.1016/j.pnpbp.2022.110581.</mixed-citation><mixed-citation xml:lang="en">Misiak B, Wójta-Kempa M, Samochowiec J, Schiweck C, Aichholzer M, et al. Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2022;118:110581. doi: 10.1016/j.pnpbp.2022.110581.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Misiak B, Bartoli F, Carrà G, Stańczykiewicz B, Gładka A, Frydecka D, et al. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis. Psychoneuroendocrinology. 2021;127:105200. doi: 10.1016/j.psyneuen.2021.105200.</mixed-citation><mixed-citation xml:lang="en">Misiak B, Bartoli F, Carrà G, Stańczykiewicz B, Gładka A, Frydecka D, et al. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis. Psychoneuroendocrinology. 2021;127:105200. doi: 10.1016/j.psyneuen.2021.105200.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Miyazaki C, Koyama M, Ota E, Swa T, Mlunde LB, Amiya RM, et al. Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):120. doi: 10.1186/s12888-017-1281-7.</mixed-citation><mixed-citation xml:lang="en">Miyazaki C, Koyama M, Ota E, Swa T, Mlunde LB, Amiya RM, et al. Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):120. doi: 10.1186/s12888-017-1281-7.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74(1):15-25. doi: 10.1016/j.biopsych.2013.01.007.</mixed-citation><mixed-citation xml:lang="en">Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74(1):15-25. doi: 10.1016/j.biopsych.2013.01.007.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Moghbeli M, Khedmatgozar H, Yadegari M, Avan A, Ferns GA, et al. Cytokines and the immune response in obesity-related disorders. Adv Clin Chem. 2021;101:135-168. doi: 10.1016/bs.acc.2020.06.004.</mixed-citation><mixed-citation xml:lang="en">Moghbeli M, Khedmatgozar H, Yadegari M, Avan A, Ferns GA, et al. Cytokines and the immune response in obesity-related disorders. Adv Clin Chem. 2021;101:135-168. doi: 10.1016/bs.acc.2020.06.004.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Moniczewski A, Gawlik M, Smaga I, Niedzielska E, Krzek J, et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacol Rep. 2015;67(3):560-8. doi: 10.1016/j.pharep.2014.12.014.</mixed-citation><mixed-citation xml:lang="en">Moniczewski A, Gawlik M, Smaga I, Niedzielska E, Krzek J, et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacol Rep. 2015;67(3):560-8. doi: 10.1016/j.pharep.2014.12.014.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;42:115-121. doi: 10.1016/j.pnpbp.2011.12.002.</mixed-citation><mixed-citation xml:lang="en">Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;42:115-121. doi: 10.1016/j.pnpbp.2011.12.002.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Motaghinejad M, Motevalian M, Shabab B, Fatima S. Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats. J Neural Transm (Vienna). 2017;124(1):121-131. doi: 10.1007/s00702-016-1623-5.</mixed-citation><mixed-citation xml:lang="en">Motaghinejad M, Motevalian M, Shabab B, Fatima S. Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats. J Neural Transm (Vienna). 2017;124(1):121-131. doi: 10.1007/s00702-016-1623-5.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Napolitano A, Manini P, d’Ischia M. Oxidation chemistry of catecholamines and neuronal degeneration: an update. Curr Med Chem. 2011;18(12):1832-45. doi: 10.2174/092986711795496863.</mixed-citation><mixed-citation xml:lang="en">Napolitano A, Manini P, d’Ischia M. Oxidation chemistry of catecholamines and neuronal degeneration: an update. Curr Med Chem. 2011;18(12):1832-45. doi: 10.2174/092986711795496863.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Neri M, Cerretani D, Fiaschi AI, Laghi PF, Lazzerini PE, Maffione AB, et al. Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J Cell Mol Med. 2007;11(1):156-70. doi: 10.1111/j.1582-4934.2007.00009.x.</mixed-citation><mixed-citation xml:lang="en">Neri M, Cerretani D, Fiaschi AI, Laghi PF, Lazzerini PE, Maffione AB, et al. Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats. J Cell Mol Med. 2007;11(1):156-70. doi: 10.1111/j.1582-4934.2007.00009.x.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007;61(12):1320-8. doi: 10.1016/j.biopsych.2006.08.049.</mixed-citation><mixed-citation xml:lang="en">Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007;61(12):1320-8. doi: 10.1016/j.biopsych.2006.08.049.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen PR, Benros ME, Dalsgaard S. Associations Between Autoimmune Diseases and Attention-Deficit/Hyperactivity Disorder: A Nationwide Study. J Am Acad Child Adolesc Psychiatry. 2017;56(3):234-240.e1. doi: 10.1016/j.jaac.2016.12.010.</mixed-citation><mixed-citation xml:lang="en">Nielsen PR, Benros ME, Dalsgaard S. Associations Between Autoimmune Diseases and Attention-Deficit/Hyperactivity Disorder: A Nationwide Study. J Am Acad Child Adolesc Psychiatry. 2017;56(3):234-240.e1. doi: 10.1016/j.jaac.2016.12.010.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Nigg J, Nikolas M, Burt SA. Measured gene-byenvironment interaction in relation to attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(9):863-73. doi: 10.1016/j.jaac.2010.01.025.</mixed-citation><mixed-citation xml:lang="en">Nigg J, Nikolas M, Burt SA. Measured gene-byenvironment interaction in relation to attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(9):863-73. doi: 10.1016/j.jaac.2010.01.025.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, et al. Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021;78(5):519-529. doi: 10.1001/jamapsychiatry.2020.4799.</mixed-citation><mixed-citation xml:lang="en">Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, et al. Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021;78(5):519-529. doi: 10.1001/jamapsychiatry.2020.4799.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Oades RD, Dauvermann MR, Schimmelmann BG, Schwarz MJ, Myint AM. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication. Behav Brain Funct. 2010;6:29. doi: 10.1186/1744-9081-6-29.</mixed-citation><mixed-citation xml:lang="en">Oades RD, Dauvermann MR, Schimmelmann BG, Schwarz MJ, Myint AM. Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism--effects of medication. Behav Brain Funct. 2010;6:29. doi: 10.1186/1744-9081-6-29.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Odell JD, Warren RP, Warren WL, Burger RA, Maciulis A. Association of genes within the major histocompatibility complex with attention deficit hyperactivity disorder. Neuropsychobiology. 1997;35(4):181-186. doi: 10.1159/000119342.</mixed-citation><mixed-citation xml:lang="en">Odell JD, Warren RP, Warren WL, Burger RA, Maciulis A. Association of genes within the major histocompatibility complex with attention deficit hyperactivity disorder. Neuropsychobiology. 1997;35(4):181-186. doi: 10.1159/000119342.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002-1012. doi: 10.1016/S2215-0366(15)00309-0.</mixed-citation><mixed-citation xml:lang="en">Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002-1012. doi: 10.1016/S2215-0366(15)00309-0.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Pennington BF, McGrath LM, Rosenberg J, Barnard H, Smith SD, et al. Gene X environment interactions in reading disability and attentiondeficit/ hyperactivity disorder. Dev Psychol. 2009;45(1):77-89. doi: 10.1037/a0014549.</mixed-citation><mixed-citation xml:lang="en">Pennington BF, McGrath LM, Rosenberg J, Barnard H, Smith SD, et al. Gene X environment interactions in reading disability and attentiondeficit/ hyperactivity disorder. Dev Psychol. 2009;45(1):77-89. doi: 10.1037/a0014549.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Pietropaolo S, Crusio WE, Feldon J. Gene- Environment Interactions in Neurodevelopmental Disorders. Neural Plast. 2017;2017:9272804. doi: 10.1155/2017/9272804.</mixed-citation><mixed-citation xml:lang="en">Pietropaolo S, Crusio WE, Feldon J. Gene- Environment Interactions in Neurodevelopmental Disorders. Neural Plast. 2017;2017:9272804. doi: 10.1155/2017/9272804.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto RQ, Soares I, Carvalho-Correia E, Mesquita AR. Gene-environment interactions in psychopathology throughout early childhood: a systematic review. Psychiatr Genet. 2015;25(6):223-233. doi: 10.1097/YPG.0000000000000106.</mixed-citation><mixed-citation xml:lang="en">Pinto RQ, Soares I, Carvalho-Correia E, Mesquita AR. Gene-environment interactions in psychopathology throughout early childhood: a systematic review. Psychiatr Genet. 2015;25(6):223-233. doi: 10.1097/YPG.0000000000000106.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Réus GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015;300:141-154. doi: 10.1016/j.neuroscience.2015.05.018.</mixed-citation><mixed-citation xml:lang="en">Réus GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015;300:141-154. doi: 10.1016/j.neuroscience.2015.05.018.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Ross BM, McKenzie I, Glen I, Bennett CP. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. NutrNeurosci. 2003;6(5):277-81. doi: 10.1080/10284150310001612203.</mixed-citation><mixed-citation xml:lang="en">Ross BM, McKenzie I, Glen I, Bennett CP. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. NutrNeurosci. 2003;6(5):277-81. doi: 10.1080/10284150310001612203.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Sandstrom A, Perroud N, Alda M, Uher R, Pavlova B. Prevalence of attention-deficit/hyperactivity disorder in people with mood disorders: A systematic review and meta-analysis. Acta Psychiatr Scand. 2021;143(5):380-391. doi: 10.1111/acps.13283.</mixed-citation><mixed-citation xml:lang="en">Sandstrom A, Perroud N, Alda M, Uher R, Pavlova B. Prevalence of attention-deficit/hyperactivity disorder in people with mood disorders: A systematic review and meta-analysis. Acta Psychiatr Scand. 2021;143(5):380-391. doi: 10.1111/acps.13283.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Schaafsma W, Basterra LB, Jacobs S, Brouwer N, Meerlo P, et al. Maternal inflammation induces immune activation of fetal microglia and leads to disrupted microglia immune responses, behavior, and learning performance in adulthood. Neurobiol Dis. 2017;106:291-300. doi: 10.1016/j.nbd.2017.07.017.</mixed-citation><mixed-citation xml:lang="en">Schaafsma W, Basterra LB, Jacobs S, Brouwer N, Meerlo P, et al. Maternal inflammation induces immune activation of fetal microglia and leads to disrupted microglia immune responses, behavior, and learning performance in adulthood. Neurobiol Dis. 2017;106:291-300. doi: 10.1016/j.nbd.2017.07.017.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Schans JV, Çiçek R, de Vries TW, Hak E, Hoekstra PJ. Association of atopic diseases and attentiondeficit/hyperactivity disorder: A systematic review and meta-analyses. NeurosciBiobehav Rev. 2017;74(Pt A):139-148. doi: 10.1016/j.neubiorev.2017.01.011.</mixed-citation><mixed-citation xml:lang="en">Schans JV, Çiçek R, de Vries TW, Hak E, Hoekstra PJ. Association of atopic diseases and attentiondeficit/hyperactivity disorder: A systematic review and meta-analyses. NeurosciBiobehav Rev. 2017;74(Pt A):139-148. doi: 10.1016/j.neubiorev.2017.01.011.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Schiweck C, Arteaga-Henriquez G, Aichholzer M, Edwin Thanarajah S, et al. Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. NeurosciBiobehav Rev. 2021;124:100-123. doi: 10.1016/j.neubiorev.2021.01.017.</mixed-citation><mixed-citation xml:lang="en">Schiweck C, Arteaga-Henriquez G, Aichholzer M, Edwin Thanarajah S, et al. Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. NeurosciBiobehav Rev. 2021;124:100-123. doi: 10.1016/j.neubiorev.2021.01.017.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitz F, Scherer EB, Machado FR, da Cunha AA, Tagliari B, et al. Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats. Metab Brain Dis. 2012;27(4):605-612. doi: 10.1007/s11011-012-9335-5.</mixed-citation><mixed-citation xml:lang="en">Schmitz F, Scherer EB, Machado FR, da Cunha AA, Tagliari B, et al. Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats. Metab Brain Dis. 2012;27(4):605-612. doi: 10.1007/s11011-012-9335-5.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Segman RH, Meltzer A, Gross-Tsur V, Kosov A, Frisch A, Inbar E, et al. Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatry. 2002;7(1):72-74. doi: 10.1038/sj.mp.4000919. PMID: 11803448.</mixed-citation><mixed-citation xml:lang="en">Segman RH, Meltzer A, Gross-Tsur V, Kosov A, Frisch A, Inbar E, et al. Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder. Mol Psychiatry. 2002;7(1):72-74. doi: 10.1038/sj.mp.4000919. PMID: 11803448.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64(6):527-532. doi: 10.1016/j.biopsych.2008.05.005.</mixed-citation><mixed-citation xml:lang="en">Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64(6):527-532. doi: 10.1016/j.biopsych.2008.05.005.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Sezen H, Kandemir H, Savik E, BasmacıKandemir S, Kilicaslan F, et al. Increased oxidative stress in children with attention deficit hyperactivity disorder. Redox Rep. 2016;21(6):248-253. doi: 10.1080/13510002.2015.1116729.</mixed-citation><mixed-citation xml:lang="en">Sezen H, Kandemir H, Savik E, BasmacıKandemir S, Kilicaslan F, et al. Increased oxidative stress in children with attention deficit hyperactivity disorder. Redox Rep. 2016;21(6):248-253. doi: 10.1080/13510002.2015.1116729.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Singh N, Das MK, Ramteke A, R P. Oxidative stress mediated hepatotoxicity induced by ZNP and modulatory role of fruit extract on male Wistar rat. Toxicol Rep. 2020;7:492-500. doi: 10.1016/j.toxrep.2020.03.009.</mixed-citation><mixed-citation xml:lang="en">Singh N, Das MK, Ramteke A, R P. Oxidative stress mediated hepatotoxicity induced by ZNP and modulatory role of fruit extract on male Wistar rat. Toxicol Rep. 2020;7:492-500. doi: 10.1016/j.toxrep.2020.03.009.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep. 2015;67(3):569-580. doi: 10.1016/j.pharep.2014.12.015.</mixed-citation><mixed-citation xml:lang="en">Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, et al. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep. 2015;67(3):569-580. doi: 10.1016/j.pharep.2014.12.015.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Smith TF, Anastopoulos AD, Garrett ME, Arias-Vasquez A, Franke B, Oades RD, et al. Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity. Am J Med Genet B Neuropsychiatr Genet. 2014;165B(8):691-704. doi: 10.1002/ajmg.b.32275.</mixed-citation><mixed-citation xml:lang="en">Smith TF, Anastopoulos AD, Garrett ME, Arias-Vasquez A, Franke B, Oades RD, et al. Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity. Am J Med Genet B Neuropsychiatr Genet. 2014;165B(8):691-704. doi: 10.1002/ajmg.b.32275.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Solleiro-Villavicencio H, Rivas-Arancibia S. Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases. Front Cell Neurosci. 2018;12:114. doi: 10.3389/fncel.2018.00114.</mixed-citation><mixed-citation xml:lang="en">Solleiro-Villavicencio H, Rivas-Arancibia S. Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases. Front Cell Neurosci. 2018;12:114. doi: 10.3389/fncel.2018.00114.</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Song Y, Lu M, Yuan H, Chen T, Han X. Mast cell-mediated neuroinflammation may have a role in attention deficit hyperactivity disorder (Review). Exp Ther Med. 2020;20(2):714-726. doi: 10.3892/etm.2020.8789.</mixed-citation><mixed-citation xml:lang="en">Song Y, Lu M, Yuan H, Chen T, Han X. Mast cell-mediated neuroinflammation may have a role in attention deficit hyperactivity disorder (Review). Exp Ther Med. 2020;20(2):714-726. doi: 10.3892/etm.2020.8789.</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Spencer WA, Jeyabalan J, Kichambre S, Gupta RC. Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species. Free Radic Biol Med. 2011;50(1):139-147. doi: 10.1016/j.freeradbiomed.2010.10.693.</mixed-citation><mixed-citation xml:lang="en">Spencer WA, Jeyabalan J, Kichambre S, Gupta RC. Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species. Free Radic Biol Med. 2011;50(1):139-147. doi: 10.1016/j.freeradbiomed.2010.10.693.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology. 2006 May;50(6):755-760. doi: 10.1016/j.neuropharm.2005.11.022.</mixed-citation><mixed-citation xml:lang="en">Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology. 2006 May;50(6):755-760. doi: 10.1016/j.neuropharm.2005.11.022.</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Terasaki LS, Schwarz JM. Effects of Moderate Prenatal Alcohol Exposure during Early Gestation in Rats on Inflammation across the Maternal-Fetal- Immune Interface and Later-Life Immune Function in the Offspring. J Neuroimmune Pharmacol. 2016;11(4):680-692. doi: 10.1007/s11481-016-9691-8.</mixed-citation><mixed-citation xml:lang="en">Terasaki LS, Schwarz JM. Effects of Moderate Prenatal Alcohol Exposure during Early Gestation in Rats on Inflammation across the Maternal-Fetal- Immune Interface and Later-Life Immune Function in the Offspring. J Neuroimmune Pharmacol. 2016;11(4):680-692. doi: 10.1007/s11481-016-9691-8.</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Varol Tas F, Guvenir T, Tas G, Cakaloz B, Ormen M. Nitric oxide levels in disruptive behavioral disorder. Neuropsychobiology. 2006;53(4):176-180. doi: 10.1159/000093781.</mixed-citation><mixed-citation xml:lang="en">Varol Tas F, Guvenir T, Tas G, Cakaloz B, Ormen M. Nitric oxide levels in disruptive behavioral disorder. Neuropsychobiology. 2006;53(4):176-180. doi: 10.1159/000093781.</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Verlaet AAJ, Breynaert A, Ceulemans B, De Bruyne T, Fransen E, et al. Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison. Eur Child Adolesc Psychiatry. 2019;28(5):719-729. doi: 10.1007/s00787-018-1239-4.</mixed-citation><mixed-citation xml:lang="en">Verlaet AAJ, Breynaert A, Ceulemans B, De Bruyne T, Fransen E, et al. Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison. Eur Child Adolesc Psychiatry. 2019;28(5):719-729. doi: 10.1007/s00787-018-1239-4.</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Xiang-Dong P, Zhang L, Hong C, Jingjing K, Jinping J. Correlation between interleukin-1b, interleukin-6, tumor necrosis factor-a and attention deficit hyperactivity disorder. Matern Child Health Care China 2012;27:370-373.</mixed-citation><mixed-citation xml:lang="en">Xiang-Dong P, Zhang L, Hong C, Jingjing K, Jinping J. Correlation between interleukin-1b, interleukin-6, tumor necrosis factor-a and attention deficit hyperactivity disorder. Matern Child Health Care China 2012;27:370-373.</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Ystrom E, Gustavson K, Brandlistuen RE, Knudsen GP, Magnus P, et al. Prenatal Exposure to Acetaminophen and Risk of ADHD. Pediatrics. 2017;140(5):e20163840. doi: 10.1542/peds.2016-3840.</mixed-citation><mixed-citation xml:lang="en">Ystrom E, Gustavson K, Brandlistuen RE, Knudsen GP, Magnus P, et al. Prenatal Exposure to Acetaminophen and Risk of ADHD. Pediatrics. 2017;140(5):e20163840. doi: 10.1542/peds.2016-3840.</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Zalcman S, Green-Johnson JM, Murray L, Nance DM, et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 1994;643(1-2):40-49. doi: 10.1016/0006-8993(94)90006-x.</mixed-citation><mixed-citation xml:lang="en">Zalcman S, Green-Johnson JM, Murray L, Nance DM, et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 1994;643(1-2):40-49. doi: 10.1016/0006-8993(94)90006-x.</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Zayats T, Athanasiu L, Sonderby I, Djurovic S, Westlye LT, Tamnes CK, et al. Genome-wide analysis of attention deficit hyperactivity disorder in Norway. PLoS One. 2015;10(4):e0122501. doi: 10.1371/journal.pone.0122501.</mixed-citation><mixed-citation xml:lang="en">Zayats T, Athanasiu L, Sonderby I, Djurovic S, Westlye LT, Tamnes CK, et al. Genome-wide analysis of attention deficit hyperactivity disorder in Norway. PLoS One. 2015;10(4):e0122501. doi: 10.1371/journal.pone.0122501.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
